Table 2.
Women | Men | |||||||
---|---|---|---|---|---|---|---|---|
Naltrexone | Placebo | Naltrexone | Placebo | |||||
N=29 | N=28 | N=78 | N=76 | |||||
N | % | N | % | N | % | N | % | |
Race (%Caucasian) | 24 | 83 | 25 | 89 | 67 | 86 | 64 | 84 |
Employed Full Time | 21 | 72 | 21 | 75 | 70 | 90 | 68 | 89 |
Married | 13 | 45 | 11 | 39 | 34 | 44 | 38 | 50 |
Smoking | 16 | 55 | 10 | 34 | 47 | 60 | 34 | 45 |
mean±sd | mean±sd | mean±sd | mean±sd | |||||
Age | 43±9 | 46±10 | 44±11 | 42±9 | ||||
Alcohol Dependence Scale | 16±6 | 18±8 | 16±7 | 15±7 | ||||
% Days Drinking (out of last 90 days) | 82±23 | 80±23 | 81±18 | 81±22 | ||||
Drinks per drinking daya (out of last 90 days) | 8±4 | 11±6 | 13±5 | 12±5 |
There is a significant difference between sex (p=0.001) and treatment (p=0.03).